Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to prove whether general anesthesia with inhaled sevoflurane reduces the frequency of neurological and cognitive impairment after open-heart operations with use of cardiopulmonary by-pass (CPB) in comparison with intravenous anesthesia with propofol.


Clinical Trial Description

Patients assigned to the "sevoflurane" group will be anesthetized with inhaled sevoflurane (induction and conduction of general anesthesia) and empirically administered fentanyl und pancuronium. During the CPB, sevoflurane will be delivered via the oxygenator of the CPB-machine.

Patients assigned to the "propofol" group will be anesthetized with continuous propofol infusion and empirically administered fentanyl and pancuronium.

The level of anesthesia will be monitored with BIS (bi-spectral index) - desirable level of 40 - 60.

Following preoperative data will be recorded: age, years of school education, NYHA-class, LVEF by TTE, comorbidities, glucosylated hemoglobin in patients with diabetes, non-invasive arterial blood pressure the day before the operation, smoked cigarettes, alcohol abuse.

Recorded data from operation: type of surgery, CBP duration, aortic clamp duration, duration of arterial hypotension (MAP < 60 mmHg) on CPB or SAP < 90 after CPB, the lowest perfusion gradient (MAP-CVP), the lowest pO2 in arterial blood and lowest blood oxygen saturation, lowest and average brain blood saturation (measured by INVOS), steroid dosis, aprotinin dosis, mannitol dosis on CPB, epiaortic echocardiography for aortic clamping, TEE before weaning from CPB with evaluation of deaeration of the left ventricle, highest serum glucose level, highest oesophageal temperature.

Data collected after operation: time to tracheal extubation, doses of catecholamines, consciousness disorders, CRP, S-100b protein, glucose level, core temperature, ICU stay, stay at the surgery department, hospital stay.

The patients will undergo a psychological examination four times: before the operation, before discharge from hospital (usually 4-6 days after the operation), 3 and 12 months after the operation. The psychological test for evaluating the cognitive modalities will include:

1. verbal learning - the Rey's AVLT test

2. direct verbal memory - number repeating attempt from the WAIS-R/PL test

3. direct nonverbal memory - Memory Test of Geometric Figures by Benton

4. operating memory test - TMT test

5. the cognitive interference test - a modified Stroop test

6. verbal fluence - according to the Boston Test of Aphasia

7. concentration and work effectiveness - by the Number Symbol test by Wechsler.

8. mood - Beck's depression scale

9. NEECHAM Delirium Scale - during the first 24-36 hours after surgery

10. the Gough's Adjective Test will be performed with in-house relatives of the patient for evaluation the eventual emotional and eventual personality changes

Neurological examination will be performed before and 6 days after surgery. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00541918
Study type Interventional
Source Medical University of Gdansk
Contact
Status Withdrawn
Phase Phase 4
Start date June 2007
Completion date April 2015

See also
  Status Clinical Trial Phase
Recruiting NCT03894254 - Predictive Factors of Autonomy Loss in Real-life Cohort N/A
Not yet recruiting NCT03507985 - Attention and Memory Disorders Related to Acute Morphine
Terminated NCT02521558 - Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease N/A
Completed NCT00355498 - Amyloid Plaque and Tangle Imaging in Aging and Dementia
Completed NCT00010920 - Preventing Cognitive Decline With Alternative Therapies Phase 3
Not yet recruiting NCT04079075 - Multiple Interventions to Prevent Cognitive Decline N/A
Completed NCT02185222 - Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint Phase 3
Completed NCT00289471 - Identifying Patients With Dementia in Primary Care N/A
Terminated NCT00548327 - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype Phase 2
Completed NCT00403507 - Exercise Treatment of Mild-Stage Probable Alzheimer's Disease Phase 2
Completed NCT00387062 - Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment Phase 1
Completed NCT04587583 - WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers Phase 1/Phase 2
Completed NCT02843529 - Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) N/A
Active, not recruiting NCT03205709 - Cognitive Training and Neuroplasticity in Mild Cognitive Impairment N/A
Recruiting NCT05509075 - Nutraceuticals and Functional Foods
Recruiting NCT05065450 - Amygdala Memory Enhancement N/A
Recruiting NCT05929144 - Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases N/A
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Completed NCT02333942 - Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
Completed NCT02236416 - Physical Exercise for Prevention of Dementia N/A